http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2533000-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf55d0a88f05b95fbd01f520b5ba93f2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2013-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f697eab879bac76656e57bf658b3314 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c4a4d80a27ffb3aab8b1e75c6c08a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e2a06c17685f2d63eeecb4ab745d4d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2495f6d0c15c889f92c047476e3beb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb025c9fca18402981d0d719035b5f9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7783bfc469e659a48a7803a3054f369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760b44e7730009ceaa919beabb138f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e464992c49ed1955711535b2dad074c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f96741c7a6123175b698fa025c580637 |
| publicationDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2533000-C1 |
| titleOfInvention | Autograft preserving composition |
| abstract | FIELD: medicine. n SUBSTANCE: composition contains recombinant interferon specified in a group: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, antibiotics, antiseptics, hypromellose and water in the following proportions, g per 1 ml of the composition: recombinant interferon, IU - 100-1,000,000; antibiotics, g - 0.00001-0.5; antiseptics, g - 0.00001-0.5; hypromellose, g - 0.00001-0.5; water - the rest up to 1 ml. The above composition can contain broad-spectrum antibiotics specified in a group: amoxicillin, ampicillin, oxacillin, methicillin, cephalexin in an amount of 0.00001-0.5 g per 1 ml of the composition. The composition contains antiseptics specified in a group: lysozyme, biclotymol, fusafungine, ambazon, benzyldimethyl-myristoylamino-propylammonium, co-trimoxazole, amylmetacresol, dichlorobenzyl alcohol, cetylpyridinium chloride, benzoxonium chloride in an amount of 0.00001-0.5 g per 1 ml of the composition. n EFFECT: invention enables providing higher therapeutic efficacy of the composition. n 3 cl, 4 ex |
| priorityDate | 2013-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.